Cargando…

NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma

Despite the development of diagnostic and treatment strategies, the survival outcome of patients with osteosarcoma remains poor. Nod-like receptor protein 3 (NLRP3) plays a crucial role in the inflammasome pathway, which is related to the progression of various tumors. However, the effect of NLRP3 o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Zhen, Chen, Hui, Wang, Shenglin, Wei, Hongxiang, Wang, Xinwen, Shen, Rongkai, Wang, Yunqing, Lin, Rongjin, Lin, Jianhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355743/ https://www.ncbi.nlm.nih.gov/pubmed/34393801 http://dx.doi.org/10.3389/fphar.2021.724923

Ejemplares similares

Corrigendum: NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma
por: Huang, Zhen, et al.
Publicado: (2021)

Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021)

Hypoxia increases the expression of stem cell markers in human osteosarcoma cells
por: Lin, Jinluan, et al.
Publicado: (2021)

The Clinical Significance of the Expression of FEN1 in Primary Osteosarcoma
por: Zhong, Guangxian, et al.
Publicado: (2021)

Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis
por: Wei, Hongxiang, et al.
Publicado: (2022)

IQGAP3 Overexpression Correlates With Poor Prognosis and Radiation Therapy Resistance in Breast Cancer
por: Hua, Xin, et al.
Publicado: (2021)

Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma
por: Lu, Yao, et al.
Publicado: (2018)

The Role of NLRP3 Inflammasome in Alzheimer’s Disease and Potential Therapeutic Targets
por: Liang, Tao, et al.
Publicado: (2022)

Verification of TREX1 as a promising indicator of judging the prognosis of osteosarcoma
por: Feng, Jinyi, et al.
Publicado: (2016)

ACTN4 Promotes the Proliferation, Migration, Metastasis of Osteosarcoma and Enhances its Invasive Ability through the NF-κB Pathway
por: Huang, Qingshan, et al.
Publicado: (2019)

Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer
por: DUAN, JIANGMAN, et al.
Publicado: (2016)

Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
por: Tang, Xue-Feng, et al.
Publicado: (2019)

Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential
por: Sun, Ranran, et al.
Publicado: (2016)

Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma
por: Li, Zhishuang, et al.
Publicado: (2015)

Monocarboxylate Transporter 4 (MCT4) Overexpression Is Correlated with Poor Prognosis of Osteosarcoma
por: Liu, Yannan, et al.
Publicado: (2019)

Role of NLRP3 Inflammasome in Lupus Nephritis and Therapeutic Targeting by Phytochemicals
por: Wu, Dantong, et al.
Publicado: (2021)

Comprehensive analysis of cuproptosis in immune response and prognosis of osteosarcoma
por: Li, Mingzhe, et al.
Publicado: (2022)

Overexpression of lncRNA UCA1 promotes osteosarcoma progression and correlates with poor prognosis
por: Li, Wei, et al.
Publicado: (2016)

m7G-related genes predict prognosis and affect the immune microenvironment and drug sensitivity in osteosarcoma
por: Lin, Zili, et al.
Publicado: (2023)

A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro
por: Wei, Hongxiang, et al.
Publicado: (2019)

Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma
por: WANG, XUANWEI, et al.
Publicado: (2014)

YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma
por: Nigris, Filomena de, et al.
Publicado: (2011)

Identification of therapeutic targets for osteosarcoma by integrating single-cell RNA sequencing and network pharmacology
por: Wang, Yan, et al.
Publicado: (2023)

Aberrant Scinderin Expression Correlates With Liver Metastasis and Poor Prognosis in Colorectal Cancer
por: Lin, Qi, et al.
Publicado: (2019)

Overexpression of BRINP3 Predicts Poor Prognosis and Promotes Cancer Cell Proliferation and Migration via MAP4 in Osteosarcoma
por: Zeng, Wenchao, et al.
Publicado: (2022)

CNST is Characteristic of Leukemia Stem Cells and is Associated With Poor Prognosis in AML
por: Liu, Haoyu, et al.
Publicado: (2022)

GPR116 overexpression correlates with poor prognosis in gastric cancer
por: Zheng, Tian, et al.
Publicado: (2021)

Yanghe Decoction Suppresses the Experimental Autoimmune Thyroiditis in Rats by Improving NLRP3 Inflammasome and Immune Dysregulation
por: Ma, Bing’e, et al.
Publicado: (2021)

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
por: Wei, Nan, et al.
Publicado: (2022)

Molecular subtypes and scoring tools related to Foxo signaling pathway for assessing hepatocellular carcinoma prognosis and treatment responsiveness
por: Tu, Sheng, et al.
Publicado: (2023)

TUFT1 Promotes Osteosarcoma Cell Proliferation and Predicts Poor Prognosis in Osteosarcoma Patients
por: Yu, Yao-Ping, et al.
Publicado: (2018)

Natural Products as a Novel Therapeutic Strategy for NLRP3 Inflammasome-Mediated Gout
por: Lee, Jun Ho, et al.
Publicado: (2022)

HIPPO signaling-related signature for predicting prognosis and therapeutic response in gastric cancer
por: Jiang, Rui, et al.
Publicado: (2023)

Comprehensive analysis of hypoxia-related genes for prognosis value, immune status, and therapy in osteosarcoma patients
por: Han, Tao, et al.
Publicado: (2023)

DRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcoma
por: Wang, Lin, et al.
Publicado: (2017)

Ezrin overexpression predicts the poor prognosis of gastric adenocarcinoma
por: Jin, Jingchun, et al.
Publicado: (2012)

The role of NLRP3 inflammasome in hepatocellular carcinoma
por: Zhao, Huijie, et al.
Publicado: (2023)

MicroRNA-937 is overexpressed and predicts poor prognosis in patients with colon cancer
por: Liu, Huiya, et al.
Publicado: (2019)

Metadherin overexpression in perihilar cholangiocarcinoma is associated with lymph node metastasis and poor prognosis
por: Zhu, Yan-Zhi, et al.
Publicado: (2019)

The NLRP3 Inflammasome in Non-Alcoholic Fatty Liver Disease and Steatohepatitis: Therapeutic Targets and Treatment
por: Yu, Lili, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8lckria33j6ci276j7mmr3h639